Your Article Summary
Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials
The Lancet, 06/01/09
In primary prevention without previous disease, aspirin is of uncertain net value as the reduction in occlusive events needs to be weighed against any increase in major bleeds. Further trials are in progress.
Today in Over The Counter (OTC)...keeping you current
Receive free subspecialty "5-minute updates" via email
Use of over-the-counter cough and cold medications in children
Canadian Family Physician, 11/13/09
Addition of cilostazol reduces biological aspirin resistance in aspirin users with ischaemic stroke: a double-blind randomized clinical trial
European Journal of Neurology, 11/23/09
Continuation of Low-Dose Aspirin in Peptic Ulcer Bleeding. A Randomized Trial
Annals of Internal Medicine, 12/01/09

See Latest Articles